The Washington Post is reporting that GLP-1 drugs, including Ozempic, may be reshaping the brain. It said scientists believe these medications could be rewiring neural circuits involved not only in appetite but also in emotion, desire and other functions. The Post highlighted that this potential impact extends beyond the drugs' known effects on weight management.
